IL114969A0 - Carboxamide compounds - Google Patents
Carboxamide compoundsInfo
- Publication number
- IL114969A0 IL114969A0 IL11496995A IL11496995A IL114969A0 IL 114969 A0 IL114969 A0 IL 114969A0 IL 11496995 A IL11496995 A IL 11496995A IL 11496995 A IL11496995 A IL 11496995A IL 114969 A0 IL114969 A0 IL 114969A0
- Authority
- IL
- Israel
- Prior art keywords
- pct
- unsubstituted
- sec
- date
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1994/001399 WO1996006078A1 (en) | 1994-08-24 | 1994-08-24 | N-(2-(pyrrolidinyl-1)-1-phenylethyl)acetamides as kappa receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL114969A0 true IL114969A0 (en) | 1995-12-08 |
Family
ID=14098616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11496995A IL114969A0 (en) | 1994-08-24 | 1995-08-17 | Carboxamide compounds |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5837720A (de) |
| EP (1) | EP0777649B1 (de) |
| JP (1) | JP2935899B2 (de) |
| AT (1) | ATE182138T1 (de) |
| AU (1) | AU2350695A (de) |
| BR (1) | BR9503775A (de) |
| CA (1) | CA2196885C (de) |
| CO (1) | CO4410322A1 (de) |
| DE (1) | DE69510802T2 (de) |
| DK (1) | DK0777649T3 (de) |
| ES (1) | ES2133767T3 (de) |
| FI (1) | FI116056B (de) |
| GR (1) | GR3031133T3 (de) |
| IL (1) | IL114969A0 (de) |
| MX (1) | MX9701367A (de) |
| TR (1) | TR199501055A2 (de) |
| WO (2) | WO1996006078A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6239154B1 (en) | 1996-03-08 | 2001-05-29 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US5763445A (en) | 1996-03-08 | 1998-06-09 | Adolor Corporation | Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| US6133307A (en) * | 1997-04-30 | 2000-10-17 | Warner-Lambert Company | Certain benzofuranyl-N-[pyrrolidin-1-YL]-N-methyl-acetamide derivatives useful as opioid agonists |
| US5760023A (en) * | 1997-07-14 | 1998-06-02 | Adolor Corporation | Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| NZ500438A (en) * | 1997-07-14 | 2001-11-30 | Adolor Corp | Compositions containing a compound having kappa opioid agonist activity for treatment of pruritis (itchiness) |
| US6284769B1 (en) | 1999-12-03 | 2001-09-04 | The Board Of Trustees Of The University Of Illinois | Nonpeptide kappa opioid receptor antagonists |
| JP6275517B2 (ja) * | 2013-03-22 | 2018-02-07 | あゆみ製薬株式会社 | Ｉｌ−２産生抑制 |
| JP6577943B2 (ja) * | 2013-06-28 | 2019-09-18 | ネクター セラピューティクス | κオピオイド作動薬及びその使用 |
| MX2016009624A (es) * | 2014-01-24 | 2016-11-08 | Cadila Healthcare Ltd | Compuestos heterobiciclicos novedosos como agonistas del opioide kappa. |
| EP3291813A4 (de) | 2015-05-06 | 2019-01-02 | The Regents of The University of California | K-ras-modulatoren |
| TW201900638A (zh) | 2017-04-20 | 2019-01-01 | 加州大學董事會 | Ｋ－ｒａｓ調節劑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232978A (en) * | 1988-12-23 | 1993-08-03 | Merck Patent Gesellschaft Mit Beschrankter Haftung | 1-(2-arylethyl)-pyrrolidines |
| DE4034785A1 (de) * | 1990-11-02 | 1992-05-07 | Merck Patent Gmbh | 1-(2-arylethyl)-pyrrolidine |
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1994
- 1994-08-24 WO PCT/JP1994/001399 patent/WO1996006078A1/en unknown
-
1995
- 1995-05-18 CA CA002196885A patent/CA2196885C/en not_active Expired - Fee Related
- 1995-05-18 ES ES95917437T patent/ES2133767T3/es not_active Expired - Lifetime
- 1995-05-18 DE DE69510802T patent/DE69510802T2/de not_active Expired - Fee Related
- 1995-05-18 JP JP7529926A patent/JP2935899B2/ja not_active Expired - Fee Related
- 1995-05-18 MX MX9701367A patent/MX9701367A/es not_active IP Right Cessation
- 1995-05-18 EP EP95917437A patent/EP0777649B1/de not_active Expired - Lifetime
- 1995-05-18 WO PCT/IB1995/000374 patent/WO1996006077A1/en active IP Right Grant
- 1995-05-18 US US08/793,225 patent/US5837720A/en not_active Expired - Fee Related
- 1995-05-18 AT AT95917437T patent/ATE182138T1/de not_active IP Right Cessation
- 1995-05-18 AU AU23506/95A patent/AU2350695A/en not_active Abandoned
- 1995-05-18 DK DK95917437T patent/DK0777649T3/da active
- 1995-08-17 IL IL11496995A patent/IL114969A0/xx unknown
- 1995-08-23 CO CO95037814A patent/CO4410322A1/es unknown
- 1995-08-23 BR BR9503775A patent/BR9503775A/pt not_active IP Right Cessation
- 1995-08-24 TR TR95/01055A patent/TR199501055A2/xx unknown
-
1997
- 1997-02-21 FI FI970746A patent/FI116056B/fi not_active IP Right Cessation
-
1999
- 1999-09-01 GR GR990402218T patent/GR3031133T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69510802D1 (de) | 1999-08-19 |
| EP0777649A1 (de) | 1997-06-11 |
| GR3031133T3 (en) | 1999-12-31 |
| WO1996006077A1 (en) | 1996-02-29 |
| TR199501055A2 (tr) | 1996-07-21 |
| JPH09510731A (ja) | 1997-10-28 |
| EP0777649B1 (de) | 1999-07-14 |
| BR9503775A (pt) | 1996-04-16 |
| ATE182138T1 (de) | 1999-07-15 |
| FI970746A0 (fi) | 1997-02-21 |
| DE69510802T2 (de) | 1999-11-04 |
| CO4410322A1 (es) | 1997-01-09 |
| ES2133767T3 (es) | 1999-09-16 |
| CA2196885C (en) | 2001-01-23 |
| FI116056B (fi) | 2005-09-15 |
| CA2196885A1 (en) | 1996-02-29 |
| DK0777649T3 (da) | 1999-11-29 |
| AU2350695A (en) | 1996-03-14 |
| JP2935899B2 (ja) | 1999-08-16 |
| MX9701367A (es) | 1997-05-31 |
| FI970746A (fi) | 1997-02-21 |
| US5837720A (en) | 1998-11-17 |
| WO1996006078A1 (en) | 1996-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2160949T3 (es) | Derivados de fenilen-sulfonamida sustituidos en meta. | |
| JP2002531505A5 (de) | ||
| IL114969A0 (en) | Carboxamide compounds | |
| YU69902A (sh) | Novi derivati piperazina | |
| CA2143864A1 (en) | Morphinan derivatives and pharmaceutical use thereof | |
| DK0889877T3 (da) | Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer | |
| JO2239B1 (en) | Method for preparing benzothophen derivatives | |
| RU94044453A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей | |
| RU94044490A (ru) | Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани | |
| RU94044489A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования миелопероксидазной активности | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| ATE213410T1 (de) | Diclofenac/gamma-cyclodextrin klathrat komponente | |
| AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
| WO2000002877A3 (en) | New pharmaceutically active compounds | |
| KR880008999A (ko) | 3-아릴-5-알킬티오-4h-1,2,4-트리아졸 | |
| RU94044457A (ru) | Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин | |
| KR970706819A (ko) | 브라디키닌 관련 증상 억제 방법(Method of Inhibiting Conditions Associated with Bradykinin) | |
| ATE255102T1 (de) | Benzothiophenderivate, ihre herstellung und verwendung als urokinase-inhibitoren | |
| EP1051994A3 (de) | 5HT1-Rezeptor-Agonisten und COX-2 Inhibitoren zur Behandlung von Migräne | |
| MX9701529A (es) | Uso de (e)-1-[4'-(2-alquilaminoetoxi)fenil]-1-(3'-hidroxifenil)-2-f enilbut-1-enos para inhibir trastornos patologicos. | |
| NZ336969A (en) | Substituted 4-aminoalkoxy-1H-benzimidazole derivatives useful as dopamine autoreceptor (D2) agonists | |
| MY133957A (en) | "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor" | |
| SE9302334D0 (sv) | New compounds | |
| EP0810201A4 (de) | Vorbeugendes/heilendes mittel für lebererkrankungen | |
| ES2101620A1 (es) | Nuevo compuesto derivado del cromeno. |